Integral Molecular ( Integral Molecular)

Primary tabs

Integral Molecular's picture

Management

Contact Address

About Integral Molecular

Integral Molecular is a research-driven biotechnology company creating a pipeline of therapeutic antibodies against under-exploited membrane protein targets, including GPCRs, ion channels, transporters, and viral envelope proteins, using its proprietary MPS Discovery EngineĀ®.

Integral Molecular press release, blog etc

Wed, 02/05/2025 - 17:15 FDA Accepts Integral Moleculars Membrane Proteome Array Qualification Plan, Advancing the Platform for Approval as a Drug Development Tool
Thu, 01/16/2025 - 11:55 Integral Molecular Recognized as an Employer of Choice by the City of Philadelphia
Fri, 11/22/2024 - 23:16 Integral Molecular Awarded $2.7 Million to Advance the Membrane Proteome Array Towards FDA-Qualification as a Drug Development Tool
Thu, 06/06/2024 - 01:37 Integral Molecular Achieves ISO 9001 Certification for its Virology Critical Reagents Supporting Vaccine Development
Sun, 05/12/2024 - 04:20 Antibody Startup Emerges from Stealth: Cell Surface Bio Set to Transform the $10B Antibody Reagent Market
Wed, 06/08/2022 - 06:45 Integral Molecular and Optimeos Life Sciences Enter Partnership to Develop mRNA and DNA-Based Gene Therapies Using Molecular Targeting
Tue, 03/08/2022 - 07:21 Integral Molecular Partners with Philadelphia FIGHT Medical Clinic to Support Community Health
Tue, 01/04/2022 - 06:28 Integral Molecular Adds Transgenic Humanized Mice to Expand its MPS Antibody Discovery Platform Through a Partnership with Alloy Therapeutics
Wed, 08/18/2021 - 19:54 Integral Moleculars Extensive Collection of SARS-CoV-2 Reporter Virus Variants Supports the Clinical Development of Vaccines and MAbs Against Coronavirus
Thu, 07/29/2021 - 14:53 Integral Molecular Launches Transgene Protein Engineering Platform to Address Challenges in Gene Therapy
Tue, 06/15/2021 - 02:49 Integral Moleculars Rapid SARS-CoV-2 Epitope Mapping Supports Regulatory Requirements for the Development of Therapeutic Antibodies Effective Against Viral Variants
Tue, 06/08/2021 - 00:14 Integral Molecular Expands Partnership with Japans Life Sciences Distributor Funakoshi to Provide Access to Antibody Specificity and Epitope Mapping Services
Thu, 04/08/2021 - 12:07 Context Therapeutics and Integral Molecular Enter Collaboration and License Deal for Novel Claudin 6 Antibodies for Gynecologic Cancer Therapeutic Program
Wed, 02/10/2021 - 09:13 Integral Molecular Enables Rapid Resistance Testing of Vaccines and Drugs Against Emerging Coronavirus Variants
Thu, 01/07/2021 - 07:33 Integral Molecular and Optimeos Partner to Deliver Long-acting Therapeutic Antibodies Using Nanoparticle Formulation Technology
Mon, 07/13/2020 - 15:29 Integral Molecular Expands its Reporter Virus Technology to Enable Broad Testing for Coronavirus Protection Against Emerging Strains Including D614G
Wed, 06/10/2020 - 15:01 Integral Molecular Provides Rapid Safety Testing of COVID-19 Antibody Therapeutics with its Membrane Proteome Array Technology
Thu, 04/30/2020 - 13:21 Integral Molecular Develops Test for Neutralizing Antibodies in COVID-19 Patients and Clinical Trials